Brief: Kancera Q2 Operating Loss Widens To SEK 13.9 Million

Novakand Pharma AB

21/08/2020 07:19

Aug 21 (Reuters) - Kancera AB  KANC.ST :
    * Q2 OPERATING  LOSS SEK 13.9 MILLION VERSUS LOSS SEK 12.7
MILLION
YEAR AGO
    * Q2 NET SALES SEK 2.6 MILLION VERSUS SEK 0 MILLION YEAR AGO
    * COVID-19 HAS NOT HAD ANY SIGNIFICANT NEGATIVE CONSEQUENCES
FOR
BUSINESS

Source text for Eikon:  ID:nWkrY8DQJ 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))